Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McGill University
$105,000.00
Investigating the Mechanisms of Immune Evasion by a Brazilian Zika Virus Isolate
FY 2018-19
Summary
Zika virus (ZIKV) has recently emerged as a major global health burden, causing numerous outbreaks across South America since early 2015. The most concerning characteristic of these outbreaks is that ZIKV has become associated with more severe disease. This includes neurological symptoms like Guillain-Barré Syndrome, which causes paralysis, and fetal microcephaly, a condition that leads to children being born with poorly formed brains and heads. To understand this sudden change, our laboratory has established a mouse model of ZIKV infection, which we will use to study the immune response to various ZIKV strains that have or have not been associated with these complications. Our data indicate that recent strains are able to suppress important aspects of the anti-viral immune response in order to establish longer-lasting infections. We anticipate that recent strains are able to actively suppress the immune response by disrupting the production of a key anti-viral molecule, type I interferon, by the "first responders" of the immune system, innate immune cells. In addition, it has been shown that pregnancy temporarily weakens the mother's immune system to protect the developing fetus. Using our mouse model, we will explore the impact this has on the immune response to ZIKV during pregnancy, and how this relates to the fetal microcephaly seen during recent ZIKV outbreaks. Together, these studies will tell us how the virus has changed over time to evade the host immune response and establish more severe infections. We can use this information to develop vaccines and identify targets for anti-viral therapies to protect against and treat ZIKV infection.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
404118
Name
Pardy Ryan
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating the Mechanisms of Immune Evasion by a Brazilian Zika Virus Isolate
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cd8 T Cells; Innate Immunity; Mouse Models; Type I Interferon; Viral Immunology; Zika Virus
Abstract
Zika virus (ZIKV) has recently emerged as a major global health burden, causing numerous outbreaks across South America since early 2015. The most concerning characteristic of these outbreaks is that ZIKV has become associated with more severe disease. This includes neurological symptoms like Guillain-Barré Syndrome, which causes paralysis, and fetal microcephaly, a condition that leads to children being born with poorly formed brains and heads. To understand this sudden change, our laboratory has established a mouse model of ZIKV infection, which we will use to study the immune response to various ZIKV strains that have or have not been associated with these complications. Our data indicate that recent strains are able to suppress important aspects of the anti-viral immune response in order to establish longer-lasting infections. We anticipate that recent strains are able to actively suppress the immune response by disrupting the production of a key anti-viral molecule, type I interferon, by the "first responders" of the immune system, innate immune cells. In addition, it has been shown that pregnancy temporarily weakens the mother's immune system to protect the developing fetus. Using our mouse model, we will explore the impact this has on the immune response to ZIKV during pregnancy, and how this relates to the fetal microcephaly seen during recent ZIKV outbreaks. Together, these studies will tell us how the virus has changed over time to evade the host immune response and establish more severe infections. We can use this information to develop vaccines and identify targets for anti-viral therapies to protect against and treat ZIKV infection.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Pardy, Ryan
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~